Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Heart Failure

Free Subscription Articles published in Heart Retrieve available abstracts of 143 articles: HTML format

Single Articles

October 2026
1. CHRISTENSEN MK, Pedersen AK, Hyldgard VB, Moller JE, et al
   Timing of heart failure diagnosis and uptake of newly recommended therapies following clinical guideline updates.
   Heart. 2026 Oct 8:heartjnl-2025-327578. doi: 10.1136/heartjnl-2025-327578.
   PubMed    
   
   
   September 2026
2. IACOVELLI JJ, Wray DW, Carter SJ
   Reframing transthyretin amyloidosis cardiomyopathy in the context of heart failure.
   Heart. 2026 Sep 16:heartjnl-2026-328728. doi: 10.1136/heartjnl-2026-328728.
   PubMed    
   
   
   
3. GUDER G, Stork S, Frantz S, Sahiti F, et al
   Discordance between N-terminal pro-B-type natriuretic peptide and left ventricular end-diastolic pressure in suspected heart failure with a preserved ejection fraction: implications for diagnosis and prognosis.
   Heart. 2026 Sep 15:heartjnl-2026-328688. doi: 10.1136/heartjnl-2026-328688.
   PubMed     Abstract available
   
   
   August 2026
4. ERHARDSSON M, Lund L, Benson L, Savarese G, et al
   Weight loss as a marker of successful decongestion during acute heart failure hospitalisation.
   Heart. 2026 Aug 25:heartjnl-2026-328175. doi: 10.1136/heartjnl-2026-328175.
   PubMed     Abstract available
   
   
   
5. SCHIOPU A, Svedlund S, Narasimhan G, Juin Loong B, et al
   Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome.
   Heart. 2026;112:1014-1021.
   PubMed     Abstract available
   
   
   
6. INUKAI K, Takefuji M, Kazama S, Ito R, et al
   Prognostic and exploratory neurohormonal correlates of hypochloraemia in heart failure: a multicentre cohort study.
   Heart. 2026 Aug 20:heartjnl-2026-328053. doi: 10.1136/heartjnl-2026-328053.
   PubMed     Abstract available
   
   
   
7. PACK SJJ, Sawant S, Abhayaratna C, Wang N, et al
   Effects of pharmacological blood pressure lowering in heart failure with mildly reduced or preserved ejection fraction: a meta-analysis.
   Heart. 2026 Aug 7:heartjnl-2026-327872. doi: 10.1136/heartjnl-2026-327872.
   PubMed     Abstract available
   
   
   
8. GILL A, Li T, Jimenez S, Cadeiras M, et al
   Bidirectional links between heart failure and cancer: shared pathophysiology, clinical outcomes and collaborative management.
   Heart. 2026 Aug 3:heartjnl-2026-328221. doi: 10.1136/heartjnl-2026-328221.
   PubMed     Abstract available
   
   
   July 2026
9. MIRZOHREH ST, Deravi N, Javanshir E, Asghari Jafarabadi M, et al
   Impact of diabetes on outcomes in hypertrophic cardiomyopathy: a GRADE meta-analysis.
   Heart. 2026;112:876-888.
   PubMed     Abstract available
   
   
   June 2026
10. PNG ME, Tahsina T, Jones NR, Taylor CJ, et al
    Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.
    Heart. 2026 Jun 26:heartjnl-2026-328059. doi: 10.1136/heartjnl-2026-328059.
    PubMed     Abstract available
    
    
    
11. NOMA H, Kurita N, Fukuma S, Fujisawa T, et al
    Heart failure and renal outcomes with angiotensin receptor blockers compared with calcium channel blockers in patients with chronic kidney disease: a target trial emulation.
    Heart. 2026 Jun 23:heartjnl-2026-328193. doi: 10.1136/heartjnl-2026-328193.
    PubMed     Abstract available
    
    
    
12. BERNARD A
    Aortic stenosis in patients with heart failure: anything but benign.
    Heart. 2026 Jun 2:heartjnl-2025-327713. doi: 10.1136/heartjnl-2025-327713.
    PubMed    
    
    
    May 2026
13. SHERGILL S, Dattani A, Kanagala P, Singh A, et al
    Prognostic value of pulmonary transit time by cardiovascular MRI in heart failure with preserved ejection fraction.
    Heart. 2026 May 28:heartjnl-2026-328139. doi: 10.1136/heartjnl-2026-328139.
    PubMed     Abstract available
    
    
    
14. CELUTKIENE J
    Against the odds: improving survival in acute heart failure.
    Heart. 2026 May 13:heartjnl-2026-328004. doi: 10.1136/heartjnl-2026-328004.
    PubMed    
    
    
    
15. LOGEART D, Alos B, Legalloisl D, Guillaume C, et al
    Temporal trends in characteristics, management and prognosis of patients with acute heart failure through two repeated snapshots.
    Heart. 2026 May 13:heartjnl-2025-327454. doi: 10.1136/heartjnl-2025-327454.
    PubMed     Abstract available
    
    
    
16. GONZALEZ-MANZANARES R, Rossello X
    Methodological lessons of implementation trials in heart failure.
    Heart. 2026 May 8:heartjnl-2026-328160. doi: 10.1136/heartjnl-2026-328160.
    PubMed    
    
    
    April 2026
17. FUSCO F, Scognamiglio G, Dellborg M, Dehghani P, et al
    Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience.
    Heart. 2026;112:549-556.
    PubMed     Abstract available
    
    
    
18. NAVARRO JM, Doumouras BS, Douglas W, Tieu P, et al
    Risk prediction models for incident heart failure: a systematic review and meta-analysis.
    Heart. 2026 Apr 20:heartjnl-2025-327118. doi: 10.1136/heartjnl-2025-327118.
    PubMed     Abstract available
    
    
    
19. SHIRAISHI Y, Ikemura N, Ueda I, Kohno T, et al
    Comprehensive guideline-directed medical therapy strategies on health status outcomes in patients with heart failure: the LAQUA-HF randomised clinical trial.
    Heart. 2026 Apr 20:heartjnl-2025-327642. doi: 10.1136/heartjnl-2025-327642.
    PubMed     Abstract available
    
    
    March 2026
20. MI L, Chan JSK, Wong WT, Tse G, et al
    Parsimonious echocardiography-based model for predicting long-term all-cause mortality in heart failure with preserved ejection fraction.
    Heart. 2026 Mar 24:heartjnl-2026-327898. doi: 10.1136/heartjnl-2026-327898.
    PubMed     Abstract available
    
    
    
21. 
    Correction: Atrial fibrillation and heart failure with preserved ejection fraction: diagnostic challenges and therapeutic opportunities.
    Heart. 2026;112:e3.
    PubMed    
    
    
    
22. MARIANI A, Luckham K, Miles L, Samarasekera E, et al
    Model-based cost-effectiveness analysis of first-line pharmacotherapy combinations in adults with chronic heart failure and reduced ejection fraction.
    Heart. 2026 Mar 11:heartjnl-2025-327190. doi: 10.1136/heartjnl-2025-327190.
    PubMed     Abstract available
    
    
    
23. AVERBUCH T, Greene S, Biering-Sorensen T, Kotwal S, et al
    Burden of chronic kidney disease and outcomes following hospitalisation for heart failure.
    Heart. 2026 Mar 3:heartjnl-2025-327053. doi: 10.1136/heartjnl-2025-327053.
    PubMed     Abstract available
    
    
    
24. KOBAYASHI M
    Kidney decline: an overlooked driver of mortality and healthcare burden following heart failure hospitalisation.
    Heart. 2026 Mar 3:heartjnl-2025-327647. doi: 10.1136/heartjnl-2025-327647.
    PubMed    
    
    
    February 2026
25. SATO R, Schmidt C, von Haehling S
    Invisible threats, visible consequences: metabolomic footprints of air pollution on heart failure.
    Heart. 2026 Feb 27:heartjnl-2026-327798. doi: 10.1136/heartjnl-2026-327798.
    PubMed    
    
    
    
26. SINAN UY
    Guideline-directed medical therapy in older heart failure patients: survival gains, evidence gaps and the challenge of implementation.
    Heart. 2026 Feb 26:heartjnl-2026-327799. doi: 10.1136/heartjnl-2026-327799.
    PubMed    
    
    
    
27. AZAR M, Apostolo A, Salvioni E, Galotta A, et al
    Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current era.
    Heart. 2026 Feb 11:heartjnl-2025-327208. doi: 10.1136/heartjnl-2025-327208.
    PubMed     Abstract available
    
    
    
28. TAN E, Meei-Wah C, Teo YH, Tan LF, et al
    Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis.
    Heart. 2026 Feb 11:heartjnl-2025-326305. doi: 10.1136/heartjnl-2025-326305.
    PubMed     Abstract available
    
    
    
29. LUO E, Cuthbert JJ, Kazmi S, Rigby AS, et al
    Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure.
    Heart. 2026 Feb 9:heartjnl-2025-327093. doi: 10.1136/heartjnl-2025-327093.
    PubMed     Abstract available
    
    
    
30. VERELST F, Witte KK, Ahmed FZ, Al-Khatib SM, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: diagnostic challenges and therapeutic opportunities.
    Heart. 2026 Feb 5:heartjnl-2025-326954. doi: 10.1136/heartjnl-2025-326954.
    PubMed     Abstract available
    
    
    January 2026
31. HEITZINGER G, Torrefranca CS, Koschatko S, Jantsch C, et al
    Impact and prognostic implications of aortic stenosis across the heart failure spectrum: a cohort study.
    Heart. 2026 Jan 21:heartjnl-2025-326808. doi: 10.1136/heartjnl-2025-326808.
    PubMed     Abstract available
    
    
    
32. YANG C, Fan Z, Zhang J, Wu H, et al
    Air pollution-related metabolic profiles and subsequent heart failure risk.
    Heart. 2026 Jan 21:heartjnl-2025-326668. doi: 10.1136/heartjnl-2025-326668.
    PubMed     Abstract available
    
    
    
33. HERRMANN JJ, van Berlo R, Brunner-La Rocca HP, Sanders-Van Wijk S, et al
    Fluid restriction in patients with heart failure: a systematic review.
    Heart. 2026 Jan 13:heartjnl-2025-326784. doi: 10.1136/heartjnl-2025-326784.
    PubMed     Abstract available
    
    
    
34. SATO R, Schmidt C, von Haehling S
    Heart failure and fluid restriction: time to let go?
    Heart. 2026 Jan 13:heartjnl-2025-327288. doi: 10.1136/heartjnl-2025-327288.
    PubMed    
    
    
    
35. CLARK AL, Omar RZ, Ambler G, Qu C, et al
    Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and Wales.
    Heart. 2026 Jan 6:heartjnl-2025-326731. doi: 10.1136/heartjnl-2025-326731.
    PubMed     Abstract available
    
    
    December 2025
36. AHMED FZ, Harwood R, Lanctin D, Leonard C, et al
    Economic evaluation of the TriageHF Plus clinical pathway for device-based remote monitoring in heart failure.
    Heart. 2025 Dec 17:heartjnl-2025-326702. doi: 10.1136/heartjnl-2025-326702.
    PubMed     Abstract available
    
    
    
37. KIM CK, Jo S, Ha K, Kim B, et al
    Metabolic dysfunction-associated steatotic liver disease and risk of heart failure: a nationwide cohort study.
    Heart. 2025 Dec 15:heartjnl-2025-327102. doi: 10.1136/heartjnl-2025-327102.
    PubMed     Abstract available
    
    
    
38. ZAGHI A, Jujic A, Zilic H, Dieden A, et al
    Impact of cerebral oxygen saturation on mortality and rehospitalisation in patients with heart failure and the role of physical activity as a modifying factor: the HARVEST-Malmo Study.
    Heart. 2025 Dec 9:heartjnl-2025-326503. doi: 10.1136/heartjnl-2025-326503.
    PubMed     Abstract available
    
    
    November 2025
39. SHOJI S, Wilson N, Levitan EB, Judd SE, et al
    Isolated non-specific electrocardiographic ST-T abnormalities and risk of incident heart failure and its subtypes.
    Heart. 2025 Nov 17:heartjnl-2025-326798. doi: 10.1136/heartjnl-2025-326798.
    PubMed     Abstract available
    
    
    
40. MONZO L, Huttin O, Bozkurt B, Duarte K, et al
    Comparing diagnostic tools for heart failure with preserved ejection fraction across community and clinical cohorts.
    Heart. 2025 Nov 17:heartjnl-2025-326517. doi: 10.1136/heartjnl-2025-326517.
    PubMed     Abstract available
    
    
    
41. NAHIZ N, Jakobsen JC, Lukoschewitz JD, Doleman B, et al
    Combinations of diuretics for acute heart failure: a systematic review with network meta-analysis and trial sequential analysis.
    Heart. 2025 Nov 13:heartjnl-2025-326601. doi: 10.1136/heartjnl-2025-326601.
    PubMed     Abstract available
    
    
    
42. PARENTE HA, Oliveira MDSS, Cordeiro JVFA, Sforza LM, et al
    Levosimendan versus dobutamine in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Heart. 2025 Nov 12:heartjnl-2025-326744. doi: 10.1136/heartjnl-2025-326744.
    PubMed     Abstract available
    
    
    
43. WATANABE A, Miyamoto Y, Ueyama HA, Inoue K, et al
    Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation.
    Heart. 2025 Nov 11:heartjnl-2025-326949. doi: 10.1136/heartjnl-2025-326949.
    PubMed     Abstract available
    
    
    October 2025
44. WANDER G, van der Zande JA, Canpolat U, Bouchardy J, et al
    Twin pregnancies in women with heart disease are complicated by high risk of heart failure: data from the EORP ROPAC Registry.
    Heart. 2025 Oct 23:heartjnl-2025-326281. doi: 10.1136/heartjnl-2025-326281.
    PubMed     Abstract available
    
    
    
45. MONTANARO C, Mihailescu A, Sabatino J
    Twin gestation unmasks heart failure risk in women with cardiac disease.
    Heart. 2025 Oct 23:heartjnl-2025-327176. doi: 10.1136/heartjnl-2025-327176.
    PubMed    
    
    
    
46. ZHANG C, Zhong Y, Li Q, Song G, et al
    Prospective multicentre single-arm study of an interatrial shunt in heart failure with reduced ejection fraction (SUSTAIN-HF): 1-year clinical and haemodynamic outcomes.
    Heart. 2025 Oct 17:heartjnl-2025-326319. doi: 10.1136/heartjnl-2025-326319.
    PubMed     Abstract available
    
    
    
47. KILIC ME, Arayici ME, Yilancioglu RY, Turan OE, et al
    Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis.
    Heart. 2025 Oct 6:heartjnl-2025-326174. doi: 10.1136/heartjnl-2025-326174.
    PubMed     Abstract available
    
    
    September 2025
48. MU L, Larvin H, Nadarajah R, Gale CP, et al
    Long-term cardiovascular risks after atrial fibrillation diagnosis: a systematic review and meta-analysis.
    Heart. 2025 Sep 17:heartjnl-2025-326376. doi: 10.1136/heartjnl-2025-326376.
    PubMed     Abstract available
    
    
    
49. LIAO LP, Church LA, Melville H, Jayasinghe T, et al
    Effect of ketone supplementation, a low-carbohydrate diet and a ketogenic diet on heart failure measures and outcomes: a systematic review and meta-analysis.
    Heart. 2025 Sep 16:heartjnl-2025-326082. doi: 10.1136/heartjnl-2025-326082.
    PubMed     Abstract available
    
    
    
50. RAHIMI K, Gerdts E
    Beyond hypertension: quantifying the full risk landscape for heart failure in women.
    Heart. 2025 Sep 3:heartjnl-2025-326874. doi: 10.1136/heartjnl-2025-326874.
    PubMed    
    
    
    August 2025
51. DE JUAN BAGUDA J, Severo Sanchez A, de la Espriella R, Valero-Masa MJ, et al
    Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis.
    Heart. 2025 Aug 28:heartjnl-2025-326053. doi: 10.1136/heartjnl-2025-326053.
    PubMed     Abstract available
    
    
    
52. BEREZIN A
    Carbohydrate antigen 125: promising diagnostic biomarker in heart failure with preserved ejection fraction.
    Heart. 2025 Aug 28:heartjnl-2025-326900. doi: 10.1136/heartjnl-2025-326900.
    PubMed    
    
    
    
53. BUYADAA O, Wolfe R, Tonkin AM, Reid CM, et al
    Kidney function and risk of heart failure in older adults: findings from a prospective cohort study.
    Heart. 2025 Aug 22:heartjnl-2025-325700. doi: 10.1136/heartjnl-2025-325700.
    PubMed     Abstract available
    
    
    
54. JIANG M, Zhou W, Qiao HY, Zheng T, et al
    Phenotypic stratification and prognostic value of cardiac magnetic resonance in non-dilated left ventricular cardiomyopathy.
    Heart. 2025 Aug 17:heartjnl-2025-326192. doi: 10.1136/heartjnl-2025-326192.
    PubMed     Abstract available
    
    
    
55. PROIETTI M, Romiti GF
    Cardiac cachexia and sarcopenia in patients with heart failure: need for an integrated approach to patients with chronic cardiovascular diseases.
    Heart. 2025 Aug 4:heartjnl-2025-325988. doi: 10.1136/heartjnl-2025-325988.
    PubMed    
    
    
    
56. SHAN S, Sun W, Wu J, Zhu Y, et al
    Population attributable risk of traditional, under-recognised and female-specific factors for heart failure in women.
    Heart. 2025 Aug 4:heartjnl-2025-326345. doi: 10.1136/heartjnl-2025-326345.
    PubMed     Abstract available
    
    
    
57. SOTOMI Y, Matsuoka Y, Ebert C, Wang Z, et al
    Subphenogroups of acute heart failure with preserved ejection fraction: comprehensive proteomics and pathway analysis.
    Heart. 2025 Aug 1:heartjnl-2025-326091. doi: 10.1136/heartjnl-2025-326091.
    PubMed     Abstract available
    
    
    July 2025
58. MATTIG I, Romero Dorta E, Frumkin D, Kretzschmar H, et al
    Sex differences in the prevalence and prognosis of tricuspid regurgitation among patients with heart failure.
    Heart. 2025 Jul 24:heartjnl-2025-325913. doi: 10.1136/heartjnl-2025-325913.
    PubMed     Abstract available
    
    
    
59. SCIATTI E, Di Odoardo L, Zucchetti O, Senni M, et al
    Vericiguat in advanced heart failure patients receiving chronic intermittent levosimendan infusions: a prospective pilot study.
    Heart. 2025 Jul 14:heartjnl-2025-326009. doi: 10.1136/heartjnl-2025-326009.
    PubMed     Abstract available
    
    
    
60. LI H, Li L, Zou J
    Case of atypical heart failure in a middle-aged male.
    Heart. 2025;111:715-744.
    PubMed    
    
    
    June 2025
61. REDDY YNV, Miranda WR
    Haemodynamic-guided and device-free shunting for heart failure with preserved ejection fraction.
    Heart. 2025 Jun 19:heartjnl-2025-326328. doi: 10.1136/heartjnl-2025-326328.
    PubMed    
    
    
    
62. IWATSU K, Takabayashi K, Hamada T, Kubo T, et al
    Severity of mobility limitation and adverse outcomes in heart failure.
    Heart. 2025 Jun 18:heartjnl-2024-325120. doi: 10.1136/heartjnl-2024-325120.
    PubMed     Abstract available
    
    
    May 2025
63. YAN C, Li H, Wan L, Liu A, et al
    Left atrial pressure normalisation by graded radiofrequency atrial septostomy in heart failure with preserved ejection fraction: a single-arm pilot study.
    Heart. 2025 May 27:heartjnl-2025-325929. doi: 10.1136/heartjnl-2025-325929.
    PubMed     Abstract available
    
    
    
64. SONG Z, Wang SY, Qidong Z, Chen N, et al
    Catheter ablation versus medical rate control for persistent atrial fibrillation in older heart failure patients with reduced ejection fraction.
    Heart. 2025 May 20:heartjnl-2024-324668. doi: 10.1136/heartjnl-2024-324668.
    PubMed     Abstract available
    
    
    
65. YAQOOB K, Naderi H, Thomson RJ, Aksentijevic D, et al
    Prognostic impact of albuminuria in early-stage chronic kidney disease on cardiovascular outcomes: a cohort study.
    Heart. 2025;111:506-512.
    PubMed     Abstract available
    
    
    
66. CHRISTENSEN MK, Hyldgard VB, Madelaire C, Pedersen AK, et al
    Disparities in prescriptions among Danish heart failure patients: a national longitudinal cohort study.
    Heart. 2025 May 10:heartjnl-2024-325562. doi: 10.1136/heartjnl-2024-325562.
    PubMed     Abstract available
    
    
    April 2025
67. MACLEAN R, Chen Y, Lumbers RT, Shah AD, et al
    Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study.
    Heart. 2025 Apr 18:heartjnl-2024-325132. doi: 10.1136/heartjnl-2024-325132.
    PubMed     Abstract available
    
    
    
68. HUANG Y, Zhang Y, Zhang Y, Xiang H, et al
    Hearing impairment, psychological distress, and incident heart failure: a prospective cohort study.
    Heart. 2025 Apr 8:heartjnl-2024-325394. doi: 10.1136/heartjnl-2024-325394.
    PubMed     Abstract available
    
    
    March 2025
69. AL-MOHAMMAD A
    Iron deficiency, heart failure and ageing: what do we know?
    Heart. 2025 Mar 27:heartjnl-2024-325652. doi: 10.1136/heartjnl-2024-325652.
    PubMed    
    
    
    
70. LIU B, Wu X, Wang Y, Hu X, et al
    Association between cardiac cachexia and adverse outcomes in patients with heart failure: a meta-analysis of cohort studies.
    Heart. 2025 Mar 15:heartjnl-2024-325431. doi: 10.1136/heartjnl-2024-325431.
    PubMed     Abstract available
    
    
    
71. XING F, Gao M, Wu Y, Liang W, et al
    Influence of depression trajectories in heart failure patients with preserved ejection fractions: a secondary analysis of adverse outcomes in the TOPCAT trial.
    Heart. 2025 Mar 15:heartjnl-2024-324505. doi: 10.1136/heartjnl-2024-324505.
    PubMed     Abstract available
    
    
    
72. BEREZIN A
    Multifactorial management of complex comorbidity followed by heart failure, chronic kidney disease and type 2 diabetes mellitus: the way to overcome missed opportunities.
    Heart. 2025 Mar 4:heartjnl-2025-325804. doi: 10.1136/heartjnl-2025-325804.
    PubMed    
    
    
    
73. MOHAMED M, Dashtban A, Ali S, Oates T, et al
    Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study.
    Heart. 2025 Mar 4:heartjnl-2024-325046. doi: 10.1136/heartjnl-2024-325046.
    PubMed     Abstract available
    
    
    
74. HAGE C, Shahim A
    Importance of early diagnosis and implementation of guideline-directed therapies in heart failure: a message worth repeating, but we need to act!
    Heart. 2025 Mar 4:heartjnl-2024-325649. doi: 10.1136/heartjnl-2024-325649.
    PubMed    
    
    
    February 2025
75. MBANZE I, Spracklen TF, Jessen N, Damasceno A, et al
    Heart failure in low-income and middle-income countries.
    Heart. 2025 Feb 26:heartjnl-2024-324176. doi: 10.1136/heartjnl-2024-324176.
    PubMed     Abstract available
    
    
    
76. LU Y, Chen J, Chen R, Lukwaro AF, et al
    Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, cohort study.
    Heart. 2025 Feb 26:heartjnl-2024-324679. doi: 10.1136/heartjnl-2024-324679.
    PubMed     Abstract available
    
    
    
77. SQUIRE I, Kalra PR
    Cardiologists and recognition of iron deficiency in patients with heart failure.
    Heart. 2025 Feb 17:heartjnl-2024-325383. doi: 10.1136/heartjnl-2024-325383.
    PubMed    
    
    
    
78. SZE S, Squire I, Kalra PR, Cleland JG, et al
    Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial.
    Heart. 2025 Feb 12:heartjnl-2024-324908. doi: 10.1136/heartjnl-2024-324908.
    PubMed     Abstract available
    
    
    
79. MOHAMED AA, Christensen DM, Mohammad M, Torp-Pedersen C, et al
    Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failure.
    Heart. 2025 Feb 8:heartjnl-2024-325244. doi: 10.1136/heartjnl-2024-325244.
    PubMed     Abstract available
    
    
    
80. TREWAREE S, Shantsila A, Lip GYH
    Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction.
    Heart. 2025 Feb 6:heartjnl-2024-325513. doi: 10.1136/heartjnl-2024-325513.
    PubMed    
    
    
    
81. CULLER K, Zelnick LR, Mehta RC, de Sosa GR, et al
    The ICAM1 p.K56M variant and risk of heart failure in chronic kidney disease: the Chronic Renal Insufficiency Cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-325205. doi: 10.1136/heartjnl-2024-325205.
    PubMed     Abstract available
    
    
    
82. WU Y, Zhao J, Chen C, Huang J, et al
    Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-324517. doi: 10.1136/heartjnl-2024-324517.
    PubMed     Abstract available
    
    
    January 2025
83. WANG H, Gao C, Guignard-Duff M, Cole C, et al
    Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study.
    Heart. 2025 Jan 29:heartjnl-2024-324160. doi: 10.1136/heartjnl-2024-324160.
    PubMed     Abstract available
    
    
    
84. MURAYAMA A
    Industry marketing payments to physicians and prescription patterns for sacubitril/valsartan in the USA.
    Heart. 2025;111:147-150.
    PubMed     Abstract available
    
    
    
85. SIEGMUND AS, van Gelder IC, van Melle JP
    Atrial arrhythmia and heart failure in congenital heart disease: a pas de deux with consequences.
    Heart. 2025 Jan 9:heartjnl-2024-325262. doi: 10.1136/heartjnl-2024-325262.
    PubMed    
    
    
    
86. SU L, Li P, Li Z, Chen Z, et al
    Gaps in knowledge and management of iron deficiency in heart failure: a nationwide survey of cardiologists in China.
    Heart. 2025 Jan 9:heartjnl-2024-324887. doi: 10.1136/heartjnl-2024-324887.
    PubMed     Abstract available
    
    
    November 2024
87. CEELEN DCH, Bracun V, van Essen BJ, Voors AA, et al
    Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure.
    Heart. 2024 Nov 29:heartjnl-2024-324486. doi: 10.1136/heartjnl-2024-324486.
    PubMed     Abstract available
    
    
    
88. LAUWERS C, Troost E, De Meester P, Moons P, et al
    Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study.
    Heart. 2024 Nov 7:heartjnl-2024-324417. doi: 10.1136/heartjnl-2024-324417.
    PubMed     Abstract available
    
    
    
89. WANG J, Zhang Z, Sun Y, Yu B, et al
    Association of innate versus specific immunity with heart failure incidence: a prospective study.
    Heart. 2024 Nov 1:heartjnl-2024-324591. doi: 10.1136/heartjnl-2024-324591.
    PubMed     Abstract available
    
    
    October 2024
90. ACHILLI F, Maggiolini S, Madotto F, Bassetti B, et al
    Granulocyte colony-stimulating factor for stem cell mobilisation in acute myocardial infarction: a randomised controlled trial.
    Heart. 2024 Oct 14:heartjnl-2024-323926. doi: 10.1136/heartjnl-2024-323926.
    PubMed     Abstract available
    
    
    
91. SARRAZYN C, Fortuni F, Laenens D, Chua AP, et al
    Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation.
    Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526.
    PubMed     Abstract available
    
    
    September 2024
92. YU YL, Siwy J, An DW, Gonzalez A, et al
    Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.
    Heart. 2024;110:1180-1187.
    PubMed     Abstract available
    
    
    August 2024
93. WONG J, Soh CH, Wang B, Marwick T, et al
    Long-term risk of heart failure in adult cancer survivors: a systematic review and meta-analysis.
    Heart. 2024 Aug 22:heartjnl-2024-324301. doi: 10.1136/heartjnl-2024-324301.
    PubMed     Abstract available
    
    
    
94. GRAHAM FJ, Guha K, Cleland JG, Kalra PR, et al
    Treating iron deficiency in patients with heart failure: what, why, when, how, where and who.
    Heart. 2024 Aug 19:heartjnl-2022-322030. doi: 10.1136/heartjnl-2022-322030.
    PubMed     Abstract available
    
    
    April 2024
95. CUTHBERT JJ, Soyiri I, Lomax SJ, Turgoose J, et al
    Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study.
    Heart. 2024 Apr 17:heartjnl-2023-323577. doi: 10.1136/heartjnl-2023-323577.
    PubMed     Abstract available
    
    
    March 2024
96. MERCADE-BESORA N, Li X, Kolde R, Trinh NT, et al
    The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications.
    Heart. 2024 Mar 12:heartjnl-2023-323483. doi: 10.1136/heartjnl-2023-323483.
    PubMed     Abstract available
    
    
    February 2024
97. HENDRIKS PM, van den Bosch AE, Kors JA, Geenen LW, et al
    Heart rate: an accessible risk indicator in adult congenital heart disease.
    Heart. 2024;110:402-407.
    PubMed     Abstract available
    
    
    January 2024
98. DOHERTY DJ, Docherty KF, Gardner RS
    Review of the National Institute for Health and Care Excellence guidelines on chronic heart failure.
    Heart. 2024 Jan 8:heartjnl-2022-322164. doi: 10.1136/heartjnl-2022-322164.
    PubMed     Abstract available
    
    
    December 2023
99. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    PubMed     Abstract available
    
    
    
100. SUC G, Cachier A, Hentic O, Bazire B, et al
     Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours.
     Heart. 2023;110:132-139.
     PubMed     Abstract available
     
     
     
101. ALI MR, Lam CSP, Stromberg A, Hand SPP, et al
     Symptoms and signs in patients with heart failure: association with 3-month hospitalisation and mortality.
     Heart. 2023 Dec 1:heartjnl-2023-323295. doi: 10.1136/heartjnl-2023-323295.
     PubMed     Abstract available
     
     
     November 2023
102. VAZIR A, Kapelios CJ
     Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
     Heart. 2023;109:1864-1870.
     PubMed     Abstract available
     
     
     
103. CHOI S, Nah S, Cho YS, Moon I, et al
     Accuracy of visual estimation of ejection fraction in patients with heart failure using augmented reality glasses.
     Heart. 2023 Nov 8:heartjnl-2023-323067. doi: 10.1136/heartjnl-2023-323067.
     PubMed     Abstract available
     
     
     
104. SANGHA V
     Augmenting reality in echocardiography.
     Heart. 2023 Nov 8:heartjnl-2023-323443. doi: 10.1136/heartjnl-2023-323443.
     PubMed    
     
     
     October 2023
105. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
     Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
     Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
     PubMed     Abstract available
     
     
     
106. FERKH A, Clark A, Thomas L
     Left atrial phasic function: physiology, clinical assessment and prognostic value.
     Heart. 2023;109:1661-1669.
     PubMed     Abstract available
     
     
     
107. SOTOMI Y, Tamaki S, Hikoso S, Nakatani D, et al
     Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction.
     Heart. 2023 Oct 12:heartjnl-2023-323059. doi: 10.1136/heartjnl-2023-323059.
     PubMed     Abstract available
     
     
     
108. 
     Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry.
     Heart. 2023 Oct 12:heartjnl-2023-323049. doi: 10.1136/heartjnl-2023-323049.
     PubMed     Abstract available
     
     
     September 2023
109. OTTO CM
     Heartbeat: cardiopulmonary fitness as an explanation for the apparent obesity paradox in heart failure mortality risk.
     Heart. 2023;109:1499-1501.
     PubMed    
     
     
     
110. NEDEREND M, Kies P, Regeer MV, Vliegen HW, et al
     Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure.
     Heart. 2023;109:1525-1532.
     PubMed     Abstract available
     
     
     
111. FRITZ J, Belovari K, Ulmer H, Zaruba MM, et al
     Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis.
     Heart. 2023 Sep 18:heartjnl-2023-322803. doi: 10.1136/heartjnl-2023-322803.
     PubMed     Abstract available
     
     
     
112. ELTAYEB M, Squire I, Sze S
     Biomarkers in heart failure: a focus on natriuretic peptides.
     Heart. 2023 Sep 6:heartjnl-2020-318553. doi: 10.1136/heartjnl-2020-318553.
     PubMed     Abstract available
     
     
     August 2023
113. PONNUSAMY SS, Syed T, Vijayaraman P
     Pacing induced cardiomyopathy: recognition and management.
     Heart. 2023;109:1407-1415.
     PubMed     Abstract available
     
     
     
114. BRADLEY J, Schelbert EB, Bonnett LJ, Lewis GA, et al
     Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation.
     Heart. 2023 Aug 11:heartjnl-2023-322857. doi: 10.1136/heartjnl-2023-322857.
     PubMed     Abstract available
     
     
     
115. GRAHAM FJ, Friday JM, Pellicori P, Greenlaw N, et al
     Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease.
     Heart. 2023;109:1294-1301.
     PubMed     Abstract available
     
     
     
116. CHAN DZ, Grey C, Doughty RN, Lund M, et al
     Widening ethnic inequities in heart failure incidence in New Zealand.
     Heart. 2023 Aug 3:heartjnl-2023-322795. doi: 10.1136/heartjnl-2023-322795.
     PubMed     Abstract available
     
     
     July 2023
117. BEGGS SAS, Wright GA, Gardner RS
     Primary prevention implantable cardioverter defibrillators for patients with heart failure.
     Heart. 2023 Jul 18:heartjnl-2022-321728. doi: 10.1136/heartjnl-2022-321728.
     PubMed    
     
     
     
118. DIBBEN GO, Hannay JR, Taylor RS
     Exercise training in heart failure.
     Heart. 2023 Jul 17:heartjnl-2022-321132. doi: 10.1136/heartjnl-2022-321132.
     PubMed    
     
     
     
119. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
     Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
     Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
     PubMed     Abstract available
     
     
     
120. OTTO CM
     Heartbeat: Questionable benefit of beta-blocker therapy more than one year after myocardial infarction in patients without heart failure or ventricular dysfunction.
     Heart. 2023;109:1123-1125.
     PubMed    
     
     
     
121. SCHOPS LB, Sengelov M, Modin D, Jorgensen PG, et al
     Parameters associated with improvement of systolic function in patients with heart failure.
     Heart. 2023 Jul 9:heartjnl-2023-322371. doi: 10.1136/heartjnl-2023-322371.
     PubMed     Abstract available
     
     
     
122. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
     Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
     Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
     PubMed     Abstract available
     
     
     June 2023
123. YOGESWARAN V, Hidano D, Diaz AE, Van Spall HGC, et al
     Regional variations in heart failure: a global perspective.
     Heart. 2023 Jun 23:heartjnl-2022-321295. doi: 10.1136/heartjnl-2022-321295.
     PubMed     Abstract available
     
     
     
124. LAVIE CJ, Kokkinos P, Lin GM
     Obesity paradox is still alive in heart failure.
     Heart. 2023 Jun 20:heartjnl-2023-322797. doi: 10.1136/heartjnl-2023-322797.
     PubMed    
     
     
     
125. NGUYEN DD, Arnold SV
     Impact of frailty on disease-specific health status in cardiovascular disease.
     Heart. 2023;109:977-983.
     PubMed     Abstract available
     
     
     
126. FUSCO F, Scognamiglio G
     Heart failure management in adults with congenital heart disease: are we on the 'right path'?
     Heart. 2023 Jun 8:heartjnl-2023-322807. doi: 10.1136/heartjnl-2023-322807.
     PubMed    
     
     
     
127. JONES NR, Ordonez-Mena JM, Roalfe AK, Taylor KS, et al
     Body mass index and survival in people with heart failure.
     Heart. 2023 Jun 8:heartjnl-2023-322459. doi: 10.1136/heartjnl-2023-322459.
     PubMed     Abstract available
     
     
     
128. CARRERAS-MORA J, Simon-Ramon C, Vidal-Burdeus M, Rodriguez-Sotelo L, et al
     Subclinical congestion assessed by lung ultrasound in ST segment elevation myocardial infarction.
     Heart. 2023 Jun 7:heartjnl-2023-322690. doi: 10.1136/heartjnl-2023-322690.
     PubMed     Abstract available
     
     
     May 2023
129. YOGESWARAN V, Wadden E, Szewczyk W, Barac A, et al
     A narrative review of heart failure with preserved ejection fraction in breast cancer survivors.
     Heart. 2023 May 31:heartjnl-2022-321859. doi: 10.1136/heartjnl-2022-321859.
     PubMed     Abstract available
     
     
     
130. MORTON G, Moore J
     Systems of care for heart failure: bridging the divide between primary care and specialist services.
     Heart. 2023 May 5:heartjnl-2022-321757. doi: 10.1136/heartjnl-2022-321757.
     PubMed    
     
     
     
131. ISHAK D, Aktaa S, Lindhagen L, Alfredsson J, et al
     Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes.
     Heart. 2023 May 2:heartjnl-2022-322115. doi: 10.1136/heartjnl-2022-322115.
     PubMed     Abstract available
     
     
     April 2023
132. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
     Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
     Heart. 2023;109:771-778.
     PubMed     Abstract available
     
     
     
133. RAISI-ESTABRAGH Z, Cooper J, McCracken C, Crosbie EJ, et al
     Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.
     Heart. 2023 Apr 18:heartjnl-2022-321888. doi: 10.1136/heartjnl-2022-321888.
     PubMed     Abstract available
     
     
     
134. MARUT B, Charbonneau E, Curtis E, Donal E, et al
     Will computerised medical records and statistical tools really help us move towards precision medicine of heart failure with preserved ejection fraction?
     Heart. 2023 Apr 17:heartjnl-2023-322475. doi: 10.1136/heartjnl-2023-322475.
     PubMed    
     
     
     March 2023
135. JASINSKA-PIADLO A, Campbell P
     Management of patients with heart failure and preserved ejection fraction.
     Heart. 2023 Mar 22:heartjnl-2022-321097. doi: 10.1136/heartjnl-2022-321097.
     PubMed    
     
     
     
136. FORSYTH P, Beezer J, Bateman J
     Holistic approach to drug therapy in a patient with heart failure.
     Heart. 2023 Mar 10:heartjnl-2022-321764. doi: 10.1136/heartjnl-2022-321764.
     PubMed     Abstract available
     
     
     
137. SCHLENKER KA, Steiner JM
     Expanding perspective: considering opioids in the management of dyspnoea in end-stage heart failure.
     Heart. 2023 Mar 10:heartjnl-2023-322436. doi: 10.1136/heartjnl-2023-322436.
     PubMed    
     
     
     
138. KOSTOPOULOS G, Doundoulakis I, Toulis KA, Karagiannis T, et al
     Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis.
     Heart. 2023 Mar 10:heartjnl-2022-322044. doi: 10.1136/heartjnl-2022-322044.
     PubMed     Abstract available
     
     
     
139. GAERTNER J, Fusi-Schmidhauser T, Stock S, Siemens W, et al
     Effect of opioids for breathlessness in heart failure: a systematic review and meta-analysis.
     Heart. 2023 Mar 6:heartjnl-2022-322074. doi: 10.1136/heartjnl-2022-322074.
     PubMed     Abstract available
     
     
     February 2023
140. JORDAN C, Charman SJ, Batterham AM, Flynn D, et al
     Habitual physical activity levels of adults with heart failure: systematic review and meta-analysis.
     Heart. 2023 Feb 27:heartjnl-2022-321943. doi: 10.1136/heartjnl-2022-321943.
     PubMed     Abstract available
     
     
     
141. WEIR RAP
     Management of hospitalised patients with heart failure admitted to non-cardiology services.
     Heart. 2023 Feb 27:heartjnl-2022-321720. doi: 10.1136/heartjnl-2022-321720.
     PubMed    
     
     
     
142. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
     Prediction of short-term atrial fibrillation risk using primary care electronic health records.
     Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
     PubMed     Abstract available
     
     
     November 2022
143. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
     Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
     Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum